BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Citi
Baxter
US Department of Justice
Cipla
McKinsey
Queensland Health
Chubb
Teva
Farmers Insurance

Generated: January 18, 2018

DrugPatentWatch Database Preview

ACITRETIN Drug Profile

« Back to Dashboard

Drug patent expirations by year for ACITRETIN
Pharmacology for ACITRETIN
Ingredient-typeRetinoids
Drug ClassRetinoid
Medical Subject Heading (MeSH) Categories for ACITRETIN

US Patents and Regulatory Information for ACITRETIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr Labs Inc ACITRETIN acitretin CAPSULE;ORAL 091455-001 Apr 4, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc ACITRETIN acitretin CAPSULE;ORAL 202148-001 Sep 10, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Impax Labs Inc ACITRETIN acitretin CAPSULE;ORAL 202552-002 Dec 23, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sigmapharm Labs Llc ACITRETIN acitretin CAPSULE;ORAL 204633-002 May 22, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc ACITRETIN acitretin CAPSULE;ORAL 203707-001 Sep 10, 2015 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms Usa ACITRETIN acitretin CAPSULE;ORAL 202897-002 Apr 4, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sigmapharm Labs Llc ACITRETIN acitretin CAPSULE;ORAL 204633-004 May 22, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr Labs Inc ACITRETIN acitretin CAPSULE;ORAL 091455-002 Apr 4, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Impax Labs Inc ACITRETIN acitretin CAPSULE;ORAL 202552-001 Dec 23, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Impax Labs Inc ACITRETIN acitretin CAPSULE;ORAL 202552-004 Dec 23, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Julphar
Fuji
UBS
Fish and Richardson
Merck
Colorcon
Express Scripts
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot